Rationale for miR-32-5p Investigation in Breast Cancer Despite extensive research on miR-32-5p across various malignancies, its specific regulatory mechanisms in breast cancer remain incompletely characterized, particularly regarding its interaction with key oncogenic drivers like c-MYC. This evidence concerns the gene MYC and breast carcinoma.